A Zoloft while breastfeeding lawsuit targets Pfizer for failing to warn nursing mothers about the risks of sertraline passing through breast milk. In 2026, legal teams are building cases around infant harm tied to this drug exposure pathway.
If you took Zoloft while nursing, your baby may have absorbed sertraline. Studies show the drug transfers into breast milk at measurable levels. Some infants developed withdrawal symptoms, irritability, and feeding problems.
This guide breaks down the 2026 lawsuit status, who can file, expected payouts, and the evidence you need. About 10% of new mothers in the U.S. are prescribed an SSRI like Zoloft, making this a case that could affect thousands of families.
You’ll learn what separates breastfeeding claims from pregnancy claims. You’ll see the settlement numbers being discussed. And you’ll find out exactly how to take the first step.
Zoloft While Breastfeeding Lawsuit
The Zoloft while breastfeeding lawsuit is a product liability action against Pfizer alleging the company knew sertraline could harm nursing infants but failed to provide adequate warnings. These cases center on one core question: did Pfizer hide the risks?
Unlike pregnancy-related Zoloft claims, breastfeeding lawsuits focus on postnatal drug exposure. The baby wasn’t exposed in the womb. The baby was exposed through breast milk after birth.
Pfizer’s prescribing label for Zoloft acknowledges that sertraline is excreted in human milk. But critics argue the label downplays the risks. It doesn’t spell out the specific symptoms infants may experience.
| Lawsuit Element | Details |
|---|---|
| Defendant | Pfizer Inc. |
| Drug | Zoloft (sertraline hydrochloride) |
| Exposure Route | Breast milk transfer to nursing infant |
| Legal Theory | Failure to warn, product liability |
| Current Status | Individual lawsuits and attorney intake active in 2026 |
Mothers are filing these claims individually, not as part of a single class action. Each case depends on what symptoms the child developed and when the mother was prescribed the drug.
The legal argument is straightforward. Pfizer had data showing sertraline reaches infants through milk. They chose not to strengthen their warnings. Families paid the price.
Zoloft Breastfeeding Lawsuit 2026
In 2026, the Zoloft breastfeeding lawsuit is gaining momentum as attorneys accept new cases and scientific evidence continues to build. This is not a closed or settled matter.
The original Zoloft MDL (No. 2342) in the Eastern District of Pennsylvania focused on birth defects from prenatal use. That litigation saw mixed results, with some bellwether trials ending in defense verdicts. But breastfeeding claims represent a different legal angle.
Attorneys in 2026 are treating breastfeeding exposure as a distinct category. The theory is newer. The evidence base is growing. And the affected population is large.
- New case filings are being accepted by multiple firms nationwide
- Scientific literature published between 2020 and 2025 strengthens the link between breast milk sertraline and infant symptoms
- Regulatory scrutiny from the FDA has increased regarding SSRI labeling for lactating women
What makes 2026 different from past years is the shift in strategy. Lawyers aren’t pigeonholing these cases into the old MDL framework. They’re building standalone claims with pediatric medical records as the centerpiece.
If you’ve been thinking about filing, 2026 is when the legal infrastructure is most ready to support breastfeeding-specific claims.
Sertraline Breastfeeding Lawsuit
A sertraline breastfeeding lawsuit uses the drug’s generic name but targets the same issue: infant harm from the medication passing through breast milk. Sertraline is the active chemical in Zoloft.
Some mothers were prescribed generic sertraline rather than brand-name Zoloft. This matters legally because the defendant might differ. Brand-name claims go against Pfizer. Generic claims may target the generic manufacturer or, in some jurisdictions, still hold the brand-name maker liable under certain legal doctrines.
| Factor | Brand (Zoloft) | Generic (Sertraline) |
|---|---|---|
| Manufacturer | Pfizer Inc. | Various (Teva, Lupin, etc.) |
| Labeling Responsibility | Pfizer controls | Must match brand label per FDA rules |
| Legal Target | Pfizer directly | Varies by state law |
| Drug Formula | Sertraline HCl | Identical compound |
The key point: the harm is the same regardless of the label on the bottle. Sertraline is sertraline. The baby’s body doesn’t know if it came from a $200 brand-name bottle or a $15 generic.
Courts have wrestled with generic drug liability since the Supreme Court’s 2011 decision in PLIVA v. Mensing. That ruling limited failure-to-warn claims against generic makers. But several states have found workarounds.
Your attorney will determine the proper defendant based on which version you took and where you live.
Key Takeaway: Breastfeeding lawsuits against Zoloft/sertraline are a distinct legal path from pregnancy claims, and both brand-name and generic users may have options depending on state law.
Who Qualifies for Zoloft Lawsuit
You may qualify for a Zoloft lawsuit if you took sertraline while nursing and your infant developed documented health problems during or shortly after breastfeeding. The connection between your drug use and the baby’s symptoms is what matters most.
Qualifying isn’t about a single checkbox. It’s about building a fact pattern that links the medication to harm. Attorneys evaluate several factors when screening cases.
General qualification criteria include:
- You were prescribed Zoloft or generic sertraline while breastfeeding
- Your infant was exclusively or partially breastfed during your medication use
- Your child developed symptoms such as irritability, tremors, feeding difficulty, sleep disruption, or withdrawal-like behavior
- A pediatrician or medical provider documented these symptoms
- The symptoms appeared during or within weeks of breastfeeding while on the drug
Not every case will meet the threshold for filing. Attorneys look for cases with strong medical documentation. If your baby’s pediatric records show a pattern of symptoms that align with sertraline exposure, your case is stronger.
Timing also matters. Statutes of limitations vary by state, typically running 2 to 6 years from the date of injury or discovery of harm. In some states, the clock starts when you first learned the drug caused the problem, not when the symptoms appeared.
Zoloft Breast Milk Side Effects Infant
Side effects in infants exposed to Zoloft through breast milk can range from mild irritability to more serious neonatal adaptation symptoms. The effects depend on dose, duration, and the individual baby’s metabolism.
Sertraline is classified as an SSRI. It alters serotonin levels. When an infant ingests it through breast milk, even small amounts can affect a developing nervous system.
Reported infant side effects include:
- Excessive crying and irritability
- Tremors or jitteriness
- Feeding difficulties and poor weight gain
- Sleep disturbances (sleeping too much or too little)
- Vomiting or diarrhea
- Elevated heart rate
- Respiratory distress in rare cases
| Symptom Category | Specific Signs | Onset Timing |
|---|---|---|
| Neurological | Tremors, agitation, seizures (rare) | Days to weeks |
| Gastrointestinal | Poor feeding, vomiting | First week |
| Sleep Related | Insomnia, excessive drowsiness | First 2 weeks |
| Behavioral | Constant crying, difficulty soothing | First month |
The American Academy of Pediatrics has noted that while sertraline is sometimes considered “compatible” with breastfeeding, this does not mean zero risk. It means the benefits of breastfeeding may outweigh the risks in many cases. That nuance is exactly what lawsuits challenge.
Pfizer’s own data acknowledges sertraline excretion in milk. The argument is that the company should have quantified the infant risk more clearly.
Zoloft Breastfeeding Withdrawal Symptoms Baby
Babies exposed to Zoloft through breast milk can experience withdrawal-like symptoms when breastfeeding stops abruptly or when the mother discontinues the medication. This reaction is sometimes called neonatal adaptation syndrome.
It’s similar to what adults experience when they stop an SSRI cold turkey. Except the baby never chose to take the drug. The infant’s nervous system adjusted to a serotonin-altering chemical it received involuntarily.
Common withdrawal symptoms in infants:
- Increased crying and fussiness
- Muscle stiffness or rigidity
- Trembling or shaking
- Difficulty feeding or refusing the breast/bottle
- Temperature instability
- Rapid breathing
These symptoms can mimic other conditions, which is why many cases go undiagnosed. A pediatrician might attribute the fussiness to colic or reflux. Without knowing the mother takes sertraline, the connection gets missed entirely.
In lawsuit filings, this misdiagnosis pattern strengthens the plaintiff’s case. It shows that Pfizer’s failure to warn didn’t just affect mothers. It affected the doctors treating the babies too.
The withdrawal window typically lasts 48 hours to 2 weeks after exposure stops. If your baby showed these symptoms during that timeframe, it’s worth reviewing the medical records.
Key Takeaway: Infant side effects from Zoloft in breast milk are real, documented, and often misdiagnosed, which is a central argument in breastfeeding lawsuits.
Sertraline in Breast Milk Studies
Multiple peer-reviewed studies confirm that sertraline passes into breast milk at detectable levels, with the relative infant dose typically estimated at 0.5% to 3% of the maternal weight-adjusted dose. This data forms the scientific backbone of breastfeeding lawsuits.
Dr. Thomas Hale, author of “Medications and Mothers’ Milk,” rates sertraline as L2 (safer) on his lactation risk scale. But his own data shows measurable drug levels in infant serum. “Safer” doesn’t mean “safe for all babies.”
| Study/Source | Finding | Year |
|---|---|---|
| Stowe et al. | Sertraline and its metabolite detected in breast milk; infant serum levels generally low but variable | 2003 |
| Hale (Medications and Mothers’ Milk) | Relative infant dose 0.5% to 3%; rated L2 | Updated 2023 |
| Berle et al. | Some infants showed detectable serum levels of sertraline; one infant had levels above 10% maternal | 2004 |
| NIH LactMed Database | Reports of irritability, sleep disturbance, and decreased feeding in exposed infants | Ongoing |
| Weissman et al. (meta-analysis) | Sertraline milk/plasma ratio approximately 1.8; higher than previously assumed in some mothers | 2004 |
The Weissman meta-analysis is particularly important for litigation. It showed the milk-to-plasma ratio for sertraline could be higher than Pfizer’s labeling suggested. This means some babies received more of the drug than expected.
Plaintiffs’ attorneys use these studies to argue that Pfizer had access to this data. The company knew some infants would absorb clinically meaningful amounts. Yet the drug label remained vague on breastfeeding risks.
Science is not ambiguous here. The drug gets into the milk. Some babies absorb enough to cause symptoms. That’s the factual foundation of every claim.
Zoloft Breastfeeding FDA Warning
The FDA has acknowledged that Zoloft is excreted in human breast milk but has not issued a specific black box warning for breastfeeding use. The current labeling leaves the risk assessment largely to prescribing physicians.
Zoloft’s FDA-approved label states: “Sertraline and N-desmethylsertraline are present in human breast milk.” It recommends weighing the benefits of breastfeeding against the risks of drug exposure to the infant. That language has barely changed in over a decade.
What the FDA label says vs. what critics argue it should say:
| Current Label Language | What Critics Want Added |
|---|---|
| “Present in human breast milk” | Specific infant dose estimates and symptom warnings |
| “Weigh benefits vs. risks” | Clear list of documented infant adverse reactions |
| No specific infant symptom warnings | Warning about neonatal adaptation syndrome from breast milk exposure |
| No mention of withdrawal in nursing infants | Guidance on tapering if breastfeeding is discontinued |
In 2004, the FDA added a general warning for all SSRIs regarding neonatal complications from third-trimester exposure. But that warning addressed prenatal use, not breastfeeding.
The FDA’s MedWatch system has received adverse event reports related to sertraline-exposed breastfed infants. These include reports of sedation, poor feeding, and agitation. Plaintiffs argue these reports should have triggered a label revision.
The gap between what the FDA knows and what the label says is where lawsuits live. That gap is what attorneys call “failure to warn.”
Sertraline Nursing Baby Risks
The risks to a nursing baby from sertraline exposure include neurological, gastrointestinal, and behavioral effects that can appear within the first weeks of life. While many infants tolerate the exposure, a subset experiences clinically significant symptoms.
Think of it like peanut exposure. Most kids are fine. But for those who aren’t, the reaction can be serious. The problem is that parents aren’t being told their baby might be in that smaller, vulnerable group.
Risk factors that increase a nursing baby’s vulnerability:
- Premature birth (immature liver can’t metabolize the drug efficiently)
- Low birth weight
- Mother taking a higher dose of sertraline (100 mg or more daily)
- Baby is exclusively breastfed with no formula supplementation
- Baby has other medications that interact with serotonin pathways
- Genetic variations in drug metabolism (CYP2D6 poor metabolizers)
Infants who are “poor metabolizers” due to genetic differences break down sertraline much more slowly. For these babies, even small amounts in breast milk can accumulate and cause symptoms.
The LactMed database maintained by the National Institutes of Health documents cases where breastfed infants of sertraline-treated mothers showed measurable serum drug levels and corresponding symptoms. These aren’t theoretical risks. They’re reported clinical events.
Pfizer’s labeling does not address genetic variability in infant drug metabolism. It doesn’t mention premature babies as a higher-risk group. That silence is a central piece of the legal case.
Key Takeaway: Scientific studies confirm sertraline reaches infants through breast milk, some babies are genetically vulnerable, and the FDA label fails to communicate specific infant risks.
Zoloft Lawsuit Eligibility Criteria
To meet the eligibility criteria for a Zoloft breastfeeding lawsuit, you need documented proof that you took the drug while nursing and that your infant suffered adverse health effects during the exposure period. Medical records are the foundation of every viable claim.
Attorneys evaluate cases based on a checklist. Not every element needs to be perfect, but the stronger your documentation, the better your chances.
| Eligibility Factor | What You Need |
|---|---|
| Prescription proof | Pharmacy records showing Zoloft/sertraline dispensed during breastfeeding period |
| Breastfeeding documentation | Pediatric records, lactation consultant notes, or WIC records confirming breastfeeding |
| Infant symptoms | Pediatric medical records documenting symptoms consistent with sertraline exposure |
| Timing alignment | Symptoms appearing during or shortly after breastfeeding period on the medication |
| No alternative cause | Records showing symptoms weren’t fully explained by another condition |
| Statute of limitations | Claim filed within your state’s filing window (typically 2 to 6 years from discovery) |
Don’t assume you don’t qualify just because your pediatrician never specifically blamed Zoloft. Many doctors don’t make that connection in the medical chart. What matters is whether the symptoms match the known profile.
Documents to gather now:
- Your pharmacy prescription history
- Pediatric visit notes from your baby’s first 6 months
- Any emergency room visits for the infant
- Lactation consultant records
- Your own OB-GYN or psychiatrist records showing the prescription
Having these ready before your first call with an attorney speeds up the screening process significantly. Think of it like applying for a mortgage: the paperwork is tedious, but it determines whether you qualify.
Zoloft Lawsuit Settlement Amounts 2026
Zoloft lawsuit settlement amounts in 2026 are still being projected, as breastfeeding-specific cases have not yet reached a global settlement phase. Individual case values vary widely based on the severity of infant harm and the strength of documentation.
No mass settlement fund exists for breastfeeding claims as of early 2026. That doesn’t mean cases aren’t being resolved. Individual settlements occur quietly, often with confidentiality agreements attached.
| Claim Tier | Estimated Range | Factors |
|---|---|---|
| Tier 1: Mild symptoms | $25,000 to $100,000 | Temporary irritability, feeding issues; full recovery |
| Tier 2: Moderate harm | $100,000 to $500,000 | Extended medical treatment, developmental delays |
| Tier 3: Severe injury | $500,000 to $2,000,000+ | Hospitalization, lasting neurological effects, ongoing care needs |
These ranges are based on comparable pharmaceutical product liability cases involving infant harm. Actual Zoloft breastfeeding settlements may fall higher or lower depending on the facts.
The previous Zoloft MDL for birth defects did not result in a large-scale settlement. Pfizer won several bellwether trials. But breastfeeding claims are factually different. The exposure mechanism, the timing, and the failure-to-warn argument all shift the calculus.
Attorneys working on contingency typically take 33% to 40% of any settlement. That fee is standard in product liability cases and is paid only if you win or settle.
Zoloft Lawsuit Payout Per Person
The payout per person in a Zoloft breastfeeding lawsuit depends on three things: the severity of your child’s injury, the quality of your medical documentation, and whether the case resolves through settlement or trial verdict.
There is no fixed “per person” payout amount announced for 2026. Each case is evaluated individually. That said, analyzing comparable SSRI infant exposure cases gives a reasonable range.
Factors that increase your per-person payout:
- Severe or lasting infant symptoms (hospitalization, NICU stay)
- Strong medical records linking symptoms to sertraline exposure
- Long duration of breastfeeding while on the medication
- High dosage of sertraline prescribed
- No other plausible cause for the infant’s condition
- Expert medical testimony supporting causation
Factors that decrease your per-person payout:
- Mild, temporary symptoms with no lasting effects
- Gaps in medical documentation
- Infant had other health conditions unrelated to drug exposure
- Mother was on multiple medications simultaneously
- Late filing close to statute of limitations deadline
Think of it like car insurance claims. A fender bender gets a smaller check than a totaled vehicle with injuries. The same logic applies. More documented harm equals a higher payout.
Some attorneys report screening calls from mothers whose infants required NICU stays after showing withdrawal-like symptoms during breastfeeding. These cases sit at the higher end of the payout spectrum.
Key Takeaway: Settlement payouts for Zoloft breastfeeding claims in 2026 are case-specific, with projected ranges from $25,000 for mild cases to over $2 million for severe infant injuries.
Zoloft Class Action Lawsuit
There is no active class action lawsuit specifically for Zoloft breastfeeding claims as of 2026. Most Zoloft cases are handled as individual lawsuits or through multidistrict litigation, not traditional class actions.
People often confuse “class action” with “mass tort.” Here’s the difference.
| Feature | Class Action | Mass Tort / Individual Lawsuit |
|---|---|---|
| How cases are grouped | All plaintiffs treated as one class | Each case filed separately but may be coordinated |
| Individual evaluation | No; same payout for everyone in the class | Yes; each person’s damages assessed individually |
| Payout structure | Flat amount per claimant (often small) | Varies by injury severity (potentially large) |
| Common in | Consumer refund cases | Pharmaceutical injury cases |
| Current Zoloft status | No active class action for breastfeeding | Individual lawsuits being filed in 2026 |
Pharmaceutical injury cases almost always proceed as individual suits or mass torts. The reason is simple: every baby’s reaction is different. One infant may have had mild fussiness. Another may have been hospitalized. A class action would treat both the same, which isn’t fair to the family with the sicker child.
The original Zoloft MDL (No. 2342) consolidated pretrial proceedings in the Eastern District of Pennsylvania under Judge Cynthia Rufe. That MDL focused on birth defects. Breastfeeding claims were not part of that proceeding.
If enough breastfeeding cases are filed, a new MDL could be created. That would centralize discovery and pretrial motions while keeping each case’s damages assessment separate.
Zoloft Manufacturer Liability Pfizer
Pfizer faces manufacturer liability for Zoloft breastfeeding claims based on the legal theory of failure to warn. The argument: Pfizer had scientific data showing sertraline transfers into breast milk at levels that can affect infants, yet the company’s labeling did not adequately communicate this risk.
Under U.S. product liability law, drug manufacturers have a legal duty to warn consumers and physicians about known risks. This duty is ongoing. As new data emerges, the label must be updated.
Pfizer’s potential liability rests on several pillars:
- Published studies showing sertraline in breast milk at variable but sometimes significant levels
- Adverse event reports filed with the FDA documenting infant symptoms
- The company’s own clinical trial data and pharmacokinetic studies
- Comparison to competitors who provided more detailed lactation warnings
- Expert testimony from pharmacologists on what Pfizer knew and when
Pfizer has historically defended Zoloft litigation aggressively. In the birth defect MDL, Pfizer won key bellwether trials, arguing that plaintiffs failed to prove causation. The company used experts who testified that sertraline at low doses does not cause the alleged injuries.
But breastfeeding cases have a different factual profile. The drug’s presence in breast milk is undisputed. Pfizer’s own label admits it. The question isn’t “does it get there?” but “did Pfizer tell mothers enough about what happens when it does?”
That shift changes the litigation dynamic considerably.
Can I Sue for Zoloft Side Effects
Yes, you can sue for Zoloft side effects if you or your infant experienced harm that was not adequately disclosed in the drug’s warnings. Product liability law gives consumers the right to hold manufacturers accountable when their products cause injuries.
Your right to sue doesn’t depend on whether the FDA approved the drug. FDA approval doesn’t shield a company from liability if it failed to provide proper warnings about known risks.
Types of legal claims available:
- Failure to warn: Pfizer didn’t adequately inform you or your doctor about breastfeeding risks
- Design defect: The drug’s formulation is unreasonably dangerous (harder to prove for approved pharmaceuticals)
- Negligence: Pfizer failed to exercise reasonable care in testing, labeling, or monitoring the drug
- Breach of warranty: The drug didn’t perform as safely as a reasonable consumer would expect
Most breastfeeding claims will rely on failure to warn. It’s the strongest theory because the science supporting it is well established.
You don’t need to prove that Zoloft is inherently dangerous. You need to prove that Pfizer didn’t tell you about a specific, known risk. That’s a much easier argument to make.
If you’ve been wondering whether your case has merit, the answer usually comes down to documentation. Do you have records? Can a doctor connect the dots? If yes, you likely have a viable claim.
Key Takeaway: You can sue Pfizer for Zoloft side effects related to breastfeeding, and failure to warn is the strongest legal theory available for these claims in 2026.
Zoloft Lawsuit How to File
To file a Zoloft breastfeeding lawsuit, you start by contacting a product liability attorney who handles pharmaceutical cases, providing your medical records, and allowing the legal team to evaluate your claim’s strength before filing in court.
The process isn’t as complicated as it sounds. Think of it like three phases: preparation, evaluation, and action.
Step-by-step filing process:
- Gather your records. Collect pharmacy receipts, prescription records, your psychiatric or OB-GYN records, and your baby’s pediatric records from birth through the first year.
- Contact an attorney. Look for firms that specifically handle pharmaceutical product liability or mass tort cases. Many offer free case evaluations.
- Case screening. The attorney reviews your records, consults with medical experts, and determines whether your claim meets the legal threshold.
- Filing the complaint. If your case qualifies, the attorney files a formal complaint in the appropriate court, naming Pfizer (or the generic manufacturer) as the defendant.
- Discovery phase. Both sides exchange documents and take depositions. This phase can last 12 to 24 months.
- Settlement negotiation or trial. Most pharmaceutical cases settle before trial. If not, a jury decides.
| Filing Phase | Estimated Timeline |
|---|---|
| Record gathering | 2 to 4 weeks |
| Attorney consultation | 1 to 2 weeks |
| Case screening and evaluation | 2 to 8 weeks |
| Complaint filing | 1 to 2 weeks after approval |
| Discovery | 12 to 24 months |
| Settlement or trial | 6 to 18 months after discovery |
Most attorneys work on contingency. You pay nothing upfront. The attorney gets paid only if your case results in a settlement or verdict.
Zoloft Birth Defect Lawsuit Update
The Zoloft birth defect lawsuit, which is separate from breastfeeding claims, has largely concluded its MDL phase but continues to influence how new sertraline cases are filed and argued. Understanding this history helps frame the breastfeeding litigation.
MDL No. 2342 was established in 2012 in the U.S. District Court for the Eastern District of Pennsylvania. Judge Cynthia Rufe oversaw the consolidated proceedings. The MDL focused on claims that Zoloft caused heart defects and other birth abnormalities when taken during pregnancy.
Key MDL milestones:
- 2012: MDL created; hundreds of cases transferred
- 2015: First bellwether trial (Christensen v. Pfizer) resulted in defense verdict
- 2016: Second bellwether trial excluded plaintiff’s expert testimony; verdict for Pfizer
- 2016 to 2019: Many individual cases were dismissed or settled quietly
- 2020 onward: MDL effectively wound down; remaining cases remanded to original courts
| MDL Detail | Information |
|---|---|
| MDL Number | 2342 |
| Court | E.D. Pennsylvania |
| Judge | Cynthia M. Rufe |
| Focus | Birth defects from prenatal Zoloft use |
| Bellwether outcomes | Defense verdicts in key trials |
| Status in 2026 | Largely concluded; individual cases may still be pending |
Pfizer’s wins in the bellwether trials were significant but not decisive for all claims. The judge excluded certain expert testimony, which weakened the plaintiffs’ position in those specific cases.
Breastfeeding claims are not bound by the birth defect MDL’s outcomes. Different exposure pathway. Different timing. Different expert evidence. Attorneys filing breastfeeding cases in 2026 are building on lessons learned from the MDL’s shortcomings, particularly by strengthening their expert witness strategy.
The birth defect litigation chapter taught plaintiffs’ attorneys what not to do. The breastfeeding chapter is where those lessons get applied.
Key Takeaway: The Zoloft birth defect MDL largely ended with defense victories, but breastfeeding lawsuits represent a legally distinct path with different evidence and stronger failure-to-warn arguments.
Frequently Asked Questions
Can I file a Zoloft lawsuit if I took it while breastfeeding?
Yes, you can file if your infant suffered documented harm from sertraline exposure through breast milk.
Your claim would be based on Pfizer’s failure to adequately warn about breastfeeding risks.
An attorney can evaluate your case during a free consultation.
How much is the average Zoloft lawsuit settlement in 2026?
There is no official average yet since breastfeeding cases are still in early stages.
Projected individual settlements range from $25,000 to over $2 million based on injury severity.
Each case is valued individually based on medical records and documented harm.
What side effects in infants are linked to Zoloft in breast milk?
Reported effects include irritability, tremors, poor feeding, sleep disturbances, and withdrawal-like symptoms.
Some infants experienced elevated heart rate and respiratory issues.
Symptoms typically appeared within the first weeks of breastfeeding while the mother took sertraline.
Is there a deadline to file a Zoloft breastfeeding lawsuit?
Yes, every state has a statute of limitations for product liability claims, typically 2 to 6 years.
The clock may start from the date of injury or the date you discovered the connection to Zoloft.
Check your state’s specific deadline with an attorney as soon as possible.
Does Pfizer face liability for Zoloft breastfeeding risks?
Pfizer faces potential liability under failure-to-warn and product liability theories.
The company’s own label acknowledges sertraline is present in breast milk.
Lawsuits argue Pfizer did not adequately disclose the specific risks to nursing infants.
What to Do Right Now
If you took Zoloft while breastfeeding and your baby showed symptoms, start collecting your records today. Pharmacy printouts, pediatric charts, and your own prescription history are the building blocks of a claim.
Reach out to a pharmaceutical product liability attorney for a free case evaluation. Time matters because filing deadlines are real and they vary by state.
The 2026 window for these cases is open. Don’t wait until it narrows
